Managing
for success

Managing for success

Successful implementation of the Strategy will require sufficient resources. To secure these, we will develop fundraising strategies to maintain financing throughout the life of the Strategy and its implementation.

We will work to achieve the best possible impact for the communities with whom we engage, while demonstrating focus and value for money to those who fund our programmes. We pride ourselves that TDR’s lean organization is able to anticipate change and design appropriate responses based on strong systems and careful management. Solid business and management practices at all levels of our operations, in addition to adherence to WHO rules and regulations and international standards, ensure we are on track, efficient and focused.

We will drive and support TDR’s core activities of quality research, training and global engagement, by acting to:

Promote quality and values-based leadership

Ensure efficiency and value for money

Seize opportunities and manage risks

Foster a culture of results and continuous improvement

Value diversity and inclusiveness

Communicate and openly share knowledge

Nurture a motivating and conducive environment.

This six-year Strategy will cover three biennial workplans. Each of them will have clear and specific strategic goals, indicators, targets and deliverables, approved by our governance, which includes representation from countries in which we work. Progress will be measured against the agreed set of ambitious yet achievable indicators, overseen by our governance. We implement our projects in partnership with principal investigators in low- and middle-income countries. Our work is supported by a totally integrative online platform that covers everything from strategic planning to project and grant management and progress monitoring, ensuring transparency, accountability and traceability.

Monitoring and evaluating our impact

The success of this Strategy will depend on a robust monitoring and evaluation plan. Measuring success through a participatory approach will be guided by a Performance Framework established in agreement with TDR’s stakeholders. This framework provides indicators and targets that reflect TDR’s contribution to global health and the Sustainable Development Goals. The monitoring and evaluation plan aligns with TDR’s partnership working model, including early and continuous engagement with countries and stakeholders. The framework will be used to continually improve processes and results, in order to maximize the impact and sustainability of the outcomes. Learning from success and failure will continue to be embedded in the organizational culture in order to continuously improve performance.

TDR
World Health Organization
20, Avenue Appia
1211 Geneva 27
Switzerland

tdr@who.int
Visit our website: www.tdr.who.int

How to cite this document: World Health Organization & UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. (2023). TDR strategy 2024–2029: building local research solutions to improve global health. World Health Organization. https://apps.who.int/iris/handle/10665/371092. License: CC BY-NC-SA 3.0 IGO

Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that the World Health Organization (WHO), including the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), endorses any specific organization, products or services. The use of WHO and TDR logos is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO) or by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). WHO, including TDR is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.

Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.

Suggested citation. TDR annual report 2022: building the science of solutions. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.

Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris.

Sales, rights and licensing. To purchase WHO publications, see https://www.who.int/publications/book-orders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/copyright.

Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.

General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO, including TDR, concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO, including TDR, in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by WHO, including TDR, to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO, including TDR, be liable for damages arising from its use.